Cerenome, Inc. (CNSY) vs Lipocine Inc. (LPCN)
- Cerenome, Inc. CNSY 1.70 −9.57%
- Lipocine Inc. LPCN 1.56 −7.14%
Cerenome, Inc. and Lipocine Inc. are both Biotechnology companies. Cerenome, Inc. and Lipocine Inc. are of similar size ($14.3M and $13.9M). Cerenome, Inc. grew revenue faster over the last twelve months: −21.0% against −63.5%. Cerenome, Inc. has the higher net margin (−526.5% vs −755.1%) and the lower return on invested capital (−532.8% vs 0.00%). Across the 16 metrics below, Lipocine Inc. leads on 9 and Cerenome, Inc. on 7.
Valuation
Profitability
| Metric | CNSY | LPCN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (628.12%) | (800.80%) | 0.00% |
| Net margin | (526.48%) | (755.11%) | 0.00% |
| Free cash flow margin | (560.29%) | (713.02%) | 0.00% |
| Return on equity | (520.84%) | (60.94%) | (56.36%) |
| Return on assets | (181.53%) | (55.89%) | (48.04%) |
| Return on invested capital | (532.77%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack